CMN Weekly (9 May 2025) - Your Weekly CRISPR...
CMN Weekly
May. 9, 2025
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Proof Diagnostics
Main (gene editing) focus: CRISPR-based COVID-19 tests
Genome editing tool: CRISPR
Funding stage: Private
Location: Cambridge, MA, USA
Website: https://www.proofdx.com/
Proof Diagnostics is a Massachusetts-based start-up company developing improved CRISPR-based diagnostic tools. The company's technology enables simple, scalable and reliable testing with high sensitivity and time/cost-effectiveness. The company is co-founded by Feng Zhang, who is also the co-founder of Editas Medicine, Sherlock Biosciences, Beam Therapeutics and Arbor Biotechnolgies.
